OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
SB-1473
AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-
APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.
Primary Analyst: ES 3/30/25
Contributing Analyst(s): LD
Reviewer: LD
OFA Fiscal Note
State Impact: None
Municipal Impact: None
Explanation
The bill, which requires Medicaid coverage for federally approved
gene therapies to treat sickle cell disease, has no fiscal impact as it
conforms to current practice.
The Out Years
State Impact: None
Municipal Impact: None